Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00681
|
|||||
| Drug Name |
Diclofenac
|
|||||
| Synonyms |
Diclofenac (sodium matrix patch, pain)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Osteoarthritis of knee [ICD11: FA01] | Approved | [1] | |||
| Therapeutic Class |
Neurology Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H11Cl2NO2
|
|||||
| Canonical SMILES |
C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl
|
|||||
| InChI |
InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)
|
|||||
| InChIKey |
DCOPUUMXTXDBNB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 15307-86-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 296.1 | Topological Polar Surface Area | 49.3 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
4.4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10509002
, 11335447
, 11335577
, 11360686
, 11360816
, 11363824
, 11364719
, 11366386
, 11367281
, 11368948
, 11369843
, 11371489
, 11372884
, 11374190
, 11375443
, 11377110
, 11378007
, 11461658
, 11461788
, 11466622
, 11467742
, 11484817
, 11486423
, 11488807
, 11490201
, 11492321
, 11494744
, 14873560
, 24424557
, 29214789
, 29222179
, 46393862
, 46504644
, 46513484
, 47365081
, 47365082
, 47662173
, 47885304
, 48184892
, 4831
, 5394317
, 641516
, 7887044
, 7979066
, 8027112
, 8149635
, 8151929
, 827876
, 832709
, 837582
|
|||||
| ChEBI ID |
CHEBI:47381
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [3] | ||
| References | ||||||
| 1 | Diclofenac was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone. Drug Metab Dispos. 2009 Jan;37(1):129-36. | |||||
| 3 | Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport. Drug Metab Dispos. 2011 Jun;39(6):1047-53. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.